Byetta - First-in-Class Incretin Mimetic for Type 2 Diabetes
Print
If Exenatide is approved for clinical use it may enable type 2 diabetics to effectively control their blood-glucose levels while reducing or eliminating the risk of hypoglycaemia and weight gain.
